Norio Nonomura

This inventor holds 6 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Osaka University, Shionogi Company Limited, J-Chemical Corporation. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Norio Nonomura. Retrieved from https://idiyas.com/inventor/norio-nonomura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 10)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 9)

Average Co-Inventor Count = 5.7

ph-index = 2

Forward Citations = 9(Granted Patents)

Location History:

Suita, JP (2020 - 2024)
Osaka, JP (2021 - 2024)

Company Filing History:

Shionogi Company Limited

patents

1 out of 2

J-Chemical Corporation

patents

where one patent can have more than one assignee

Years Active: 2020-2026

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12635897 - Evaluation method, program, and evaluation system (2026-05-26),

2. 11951125 - Drug and production method therefor (2024-04-09),

3. 11932696 - Method of treating cancer with an anti-CCR8 that binds tumor infiltrating cells (2024-03-19),

4. 11226334 - Method, biomarker and diagnostic agent for detection of high-risk prostate cancer (2022-01-18),

5. 11103527 - Enteric coated silicon drug and production method therefor (2021-08-31),

6. 10550191 - Method of treating cancer with an anti-CCR8 having antibody-dependent cell-mediated cytotoxicity (ADCC) activity against cells expressing CCR8 (2020-02-04),

Title: Norio Nonomura: Innovator in Pharmaceutical Advancements

Introduction

Norio Nonomura is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of kidney diseases and cancer. With a total of 6 patents to his name, Nonomura's work reflects a commitment to advancing medical science.

Latest Patents

Nonomura's latest patents include a drug and production method for treating kidney diseases. This innovative drug contains silicon fine particles, which have hydrogen-generating abilities that can aid in the prevention and treatment of kidney ailments. Another notable patent focuses on a method of treating cancer using an anti-CCR8 antibody that targets tumor-infiltrating cells. This pharmaceutical composition represents a promising approach to cancer treatment.

Career Highlights

Throughout his career, Nonomura has been associated with esteemed institutions such as Osaka University and Shionogi & Company Limited. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Nonomura has worked alongside notable colleagues, including Tetsuya Yoshida and Yujiro Kidani. Their combined expertise has fostered an environment of innovation and discovery in pharmaceutical research.

Conclusion

Norio Nonomura's contributions to the field of pharmaceuticals are noteworthy, particularly in the areas of kidney disease and cancer treatment. His innovative patents and collaborations highlight his dedication to improving medical outcomes.

Profile summary based on public USPTO records.